{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Breast Cancer Risk Assessment: Evaluation of Screening Tools for Genetics Referral

Purpose of Activity

To present the details of a descriptive study conducted to compare five breast cancer risk-screening tools to help primary care providers determine which unaffected patients to refer to genetic specialists.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Analyze the information presented about the current status of breast cancer and its screening in the United States.
  2. Explain the methodology for the researchers' comparison of breast cancer risk-screening tools.
  3. Apply the results and clinical implications of the researchers' comparison of breast cancer risk-screening tools to your practice.
Price: $12.95

Credits:

  • AANP 1.3 CH / 0.5 APH
  • DC - BON 1.3 CH
  • FL - BON 1.0 CH
  • GA - BON 1.3 CH

This Activity is approved for 1.3 contact hour (s) of continuing education (which includes 0.5 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 19083840. This Activity was planned in accordance with AANP Accreditation Standards and Policies.

Awarded Advanced Pharmacology Hours







Test Code: JAANP1019
Published: Oct 2019
Expires: 10/1/2020
Passing Score: 13/18 (72%)
Authors: Deborah O. Himes, PhD; Maren L. Zaro, MSN; Mary Williams, PhD; Donna Freeborn, PhD; Dennis L. Eggett, PhD; Anita Y. Kinney, PhD